Dabigatran Etexilate CAS 211915-06-9

Product Description:

Product Name: Dabigatran etexilate CAS NO: 211915-06-9

Synonyms:

phenolsulphophthaleine sodium salt;

phenol red sodium salt;

N-[[2-[[[4-[[[(Hexyloxy)carbonyl]aMidino]iMinoMethyl]phenyl]aMino]Methyl]-1-Methyl-1H-benziMidazol-5-yl]carbonyl]-N-2-pyridyl-beta-alanine,ethyl ester;

Chemical & Physical Properties:

Appearance: White powder

Assay :≥99.00%

Density: 1.24 g/cm3

Boiling Point: 827.9℃ at 760 mmHg

Flash Point: 454.5℃

Refractive Index: 1.614

Vapor Pressure: 1.49E-27mmHg at 25℃

Safety Information:

HS Code: 2933990090

Dabigatran (Pradaxa, Prazaxa) is an anticoagulant medication that can be taken by mouth. It is being studied for various uses and in some cases is an alternative to warfarin, since it does not have to be monitored by blood tests, but offers similar results in terms of efficacy.

In case of major bleeding, there is an antidote, idarucizumab (sold under the brand name Praxbind). A large study sponsored by the manufacturer found that idarucizumab effectively reversed anticoagulation by dabigatran within minutes.

It is in the class of a direct thrombin inhibitor. It was developed by the pharmaceutical company Boehringer Ingelheim.

If you are interested in our products or have any questions, please feel free to contact us!

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.